STREAM goes Preprint with an Analysis of the Development of the Anti-cancer drug Ixabepilone

Today STREAM just uploaded its first manuscript into medRxiv, a preprint server. The manuscript, which can be accessed here, traces the clinical development process of a very uninteresting cancer drug you never heard of, ixabepilone (approved in USA, not in Europe). Our goal was to estimate the total patient benefit and burden associated with unlocking… Continue reading STREAM goes Preprint with an Analysis of the Development of the Anti-cancer drug Ixabepilone